CervoMed Inc (CRVO)
24.18
-0.22
(-0.88%)
USD |
NASDAQ |
May 09, 16:00
24.21
+0.04
(+0.14%)
After-Hours: 20:00
CervoMed Price to Book Value: 20.22 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 20.40 |
| May 07, 2024 | 20.41 |
| May 06, 2024 | 20.35 |
| May 03, 2024 | 20.13 |
| May 02, 2024 | 20.19 |
| May 01, 2024 | 20.22 |
| April 30, 2024 | 20.32 |
| April 29, 2024 | 20.69 |
| April 26, 2024 | 19.92 |
| April 25, 2024 | 20.90 |
| April 24, 2024 | 20.58 |
| April 23, 2024 | 20.32 |
| April 22, 2024 | 19.98 |
| April 19, 2024 | 20.08 |
| April 18, 2024 | 21.12 |
| April 17, 2024 | 20.91 |
| April 16, 2024 | 20.79 |
| April 15, 2024 | 19.53 |
| April 12, 2024 | 21.07 |
| April 11, 2024 | 21.08 |
| April 10, 2024 | 20.46 |
| April 09, 2024 | 19.36 |
| April 08, 2024 | 19.40 |
| April 05, 2024 | 17.15 |
| April 04, 2024 | 18.10 |
| Date | Value |
|---|---|
| April 03, 2024 | 17.59 |
| April 02, 2024 | 18.54 |
| April 01, 2024 | 18.99 |
| March 28, 2024 | 19.49 |
| March 27, 2024 | 16.41 |
| March 26, 2024 | 17.39 |
| March 25, 2024 | 17.63 |
| March 22, 2024 | 18.32 |
| March 21, 2024 | 18.80 |
| March 20, 2024 | 21.69 |
| March 19, 2024 | 20.44 |
| March 18, 2024 | 18.39 |
| March 15, 2024 | 15.06 |
| March 14, 2024 | 13.82 |
| March 13, 2024 | 14.21 |
| March 12, 2024 | 14.70 |
| March 11, 2024 | 14.79 |
| March 08, 2024 | 13.91 |
| March 07, 2024 | 13.38 |
| March 06, 2024 | 13.25 |
| March 05, 2024 | 10.87 |
| March 04, 2024 | 10.62 |
| March 01, 2024 | 10.81 |
| February 29, 2024 | 11.48 |
| February 28, 2024 | 10.59 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0864
Minimum
Nov 14 2019
21.69
Maximum
Mar 20 2024
2.344
Average
1.055
Median
Price to Book Value Benchmarks
| GlucoTrack Inc | 4.687 |
| Regen BioPharma Inc | -- |
| AIM ImmunoTech Inc | 2.207 |
| Protalix BioTherapeutics Inc | 2.677 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 105.78 |
| Price | 24.18 |
| Earnings Yield | -23.17% |
| Market Cap | 149.17M |